Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Efinaconazole bulk supplier for pharma manufacturers

Efinaconazole 10% Suppliers & Bulk Manufacturers

Available Forms: Topical Solution

Available Strengths: 10%

Reference Brands: Jublia (USA/EU)

Category: Anti-fungal

Efinaconazole topical solution is used to treat fungal or yeast infection of the toenails. This medicine works by killing the fungus or yeast or preventing its growth.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Efinaconazole — third party manufacturing & bulk supply

Efinaconazole 10% is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Efinaconazole is supplied as Topical Solution — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Efinaconazole listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Efinaconazole →
Back to Listing

Frequently Asked Questions

Efinaconazole is used to treat onychomycosis, a fungal infection of the toenails. It helps eliminate the fungus that causes nail discoloration, thickening, and damage, improving the overall appearance and health of the affected nail.

Efinaconazole is made from the triazole antifungal compound efinaconazole, which works by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes, leading to fungal cell death.

The most widely known trade name for efinaconazole is Jublia.

Efinaconazole (Jublia) is manufactured by Valeant Pharmaceuticals (now Bausch Health), along with several authorized and generic producers in different markets.

The generic name is efinaconazole.

The commonly used brand name is Jublia.

Efinaconazole is manufactured in countries such as Canada, the USA, and India by approved pharmaceutical companies depending on the brand or generic version.

Related Products

Isavuconazole

Strength:
100 mg

Form: Capsules

Reference Brands: Cresemba (USA/EU)

View Details
Clotrimazole Vaginal Tablet

Strength:
100 mg

Form: Tablets

Reference Brands: Femcare (USA), Mycelex (USA), Canesten (EU), Gyne-Lotrimin(USA)

View Details
Metronidazole / Miconazole Nitrate

Strength:
500 mg + 100 mg / 750mg+200mg

Form: Vaginal suppository

Reference Brands: Invel (USA/EU), Trimic, Inserdin, Ovulomix (LATAM)

View Details
Ketoconazole Powder

Strength:
2%

Form: Powder

Reference Brands: Generic formulations marketed under different names

View Details
Nystatin Oral Tablets 500,000 Iu

Strength:
100000 IU, 500000 IU

Form: Tablets, Oral Solution

Reference Brands: Nystatin STADA (EU), Mycostatin (USA), Bio-Statin (USA)

View Details
Nystatin Vaginal Tablets

Strength:
100000 IU, 500,000 IU

Form: Tablets

Reference Brands: Moronal (EU), Nyaderm(EU), Nystaderm(EU)

View Details
Terbinafine Tablets

Strength:
250 mg, 500 mg

Form: Tablets

Reference Brands: Lamisil (USA/EU)

View Details
Valacyclovir Tablets

Strength:
500 mg, 1000 mg

Form: Tablets

Reference Brands: Valtrex (USA/EU/UK), Zelitrex (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.